ALCAM and cerebral cortical dysplasia: The assessment of protein expression of a wide range of markers showed that the two patients with cortical dysplasia, included in this study, express higher percentages of several neuroblast and stem cell markers including DCX, NeuN, Nurr1, CD56, CD166, CD9, CD73, CD59, CD61 and cKit.